Condition: Stroke, Ischemic · Stroke, Acute · Sponsor: Hospital Moinhos de Vento
A phase III randomized, multi-center, double-blinded, placebo-controlled clinical trial that will examine two strategies for the treatment of acute ischemic stroke associated with a large vessel anterior occlusion within 4.5 hours from symptoms onset: direct endovascular treatment vs. endovascular treatment preceded by intravenous tenecteplase.
This description comes directly from the study's public registry record.
Octavio M Pontes-Neto, MD, PhD · +551636053779 · opontesneto@fmrp.usp.br
Leonardo A Carbonera, MD, MSc · +555135378195 · leonardo.carbonera@hmv.org.br
Always discuss trial participation with your own doctor first.
| Hospital Moinhos de Vento | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Hospital das Clínicas Botucatu | Botucatu, Brazil | Recruiting |
| Hospital de Base do Distrito Federal | Brasília, Brazil | Recruiting |
| Hospital das Clínicas da UFPR | Curitiba, Brazil | Recruiting |
| Hospital Geral de Fortaleza | Fortaleza, Brazil | Recruiting |
| Hospital de Clinicas de Porto Alegre | Porto Alegre, Brazil | Recruiting |
| Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto | Ribeirão Preto, Brazil | Recruiting |
| Hospital de Base de Rio Preto | São José do Rio Preto, Brazil | Recruiting |
| Hospital das Clínicas de São Paulo | São Paulo, Brazil | Recruiting |
| Hospital Sao Paulo | São Paulo, Brazil | Recruiting |
| Santa Casa de Misericordia de Sao Paulo | São Paulo, Brazil | Recruiting |
| Hospital Universitário de Uberlândia | Uberlândia, Brazil | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05199194